Vaccine trio talk up Operation Warp Speed amid Trump questions

4 September 2025

Pfizer (NYSE: PFE), Moderna (Nasdaq: MRNA) and Novavax (Nasdaq: NVAX) all issued statements Wednesday in response to comments made by US President Donald Trump.

Posting on social media, President Trump called for pharma companies to justify the success of their products for COVID-19, pointing out that while many see them as a miracle that saved millions of lives, others disagree.

Among the most prominent sceptics of the mRNA vaccines that played a key part in vaccinating the world against COVID-19 is Robert F Kennedy Jr, who this year became the US secretary of Health and Human Services.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK